Oxygen Targets in Acute Heart Failure With Pulmonary Congestion

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
Acute Heart FailurePulmonary CongestionHypoxemia
Interventions
DRUG

Oxygen

"Patients will have nasal cannula or oxygen mask placed as the usual standard of care.~Patients will be screened and randomized in the emergency department to either liberal or restrictive oxygenation after providing informed written consent and oxygen is titrated to the prespecified target range using an automated feedback device (O2MATIC). Consented patients will be randomly allocated to study groups via the web-based system within REDCap. The allocation will be concealed. Time at randomization will be considered as study time zero (T0). All patients will receive usual standard of care except for their O2 management. The intervention will last for 24 h. After 24 h, patients will be switched over to usual care for oxygen therapy. If the treating physician thinks, that the patient need another oxygenation target and it is thought to be harmful to continue with the allocated target, the intervention-phase can be stopped prematurely."

Trial Locations (2)

2200

RECRUITING

Bispebjerg Hospital, Copenhagen

2650

RECRUITING

Amager-Hvidovre Hospital, Copenhagen

All Listed Sponsors
collaborator

Bispebjerg Hospital

OTHER

lead

Copenhagen University Hospital, Hvidovre

OTHER